Table 1.
Biologics in psoriasis treatment.
| Name of the drug | Biological target |
|---|---|
| Ustekinumab | IL-12 and IL-23—p40 subunit |
| Guselkumab | IL-23—p19 subunit |
| Tildrakizumab | |
| Risankizumab | |
| Secukinumab | IL-17 |
| Ixekizumab | |
| Bimekizumab | |
| Brodalumab | IL-17 receptor |
| Etanercept | TNF-α |
| Infliximab | |
| Adalimumab | |
| Certolizumab pegol | |
| Golimumab |